Therapeutics and Targets

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 101-110 of 168 total displayed.

Past content

Review
Chronic Oxaliplatin Resistance Induces Epithelial-to-Mesenchymal Transition in Colorectal Cancer Cell Lines

Anthony D. Yang, Fan Fan, E. Ramsay Camp, George van Buren, Wenbiao Liu, Ray Somcio, Michael J. Gray, Haiyun Cheng, Paulo M. Hoff, and Lee M. Ellis
Clin. Cancer Res. 2006; 12: 4147-4153. [Abstract] [Full text] [PDF]  

Reviews
Nuclear p21-Activated Kinase 1 in Breast Cancer Packs Off Tamoxifen Sensitivity

Suresh K. Rayala, Poonam R. Molli, and Rakesh Kumar
Cancer Res. 2006; 66: 5985-5988. [Abstract] [Full text] [PDF]  

Reviews
Survivin, a cancer target with an emerging role in normal adult tissues

Seiji Fukuda and Louis M. Pelus
Mol. Cancer Ther. 2006; 5: 1087-1098. [Abstract] [Full text] [PDF]  

Review
Promise of vitamin D analogues in the treatment of hyperproliferative conditions

Sonoko Masuda and Glenville Jones
Mol. Cancer Ther. 2006; 5: 797-808. [Abstract] [Full text] [PDF]  

Reviews
The Phosphoinositide 3-Kinase/Akt1/Par-4 Axis: A Cancer-Selective Therapeutic Target

Anindya Goswami, Padhma Ranganathan, and Vivek M. Rangnekar
Cancer Res. 2006; 66: 2889-2892. [Abstract] [Full text] [PDF]  

Subject Review
Pharmacogenetics and Regulation of Human Cytochrome P450 1B1: Implications in Hormone-Mediated Tumor Metabolism and a Novel Target for Therapeutic Intervention

Tristan M. Sissung, Douglas K. Price, Alex Sparreboom, and William D. Figg
Mol. Cancer Res. 2006; 4: 135-150. [Abstract] [Full text] [PDF]  

Review
Targeted therapy by disabling crossroad signaling networks: the survivin paradigm

Dario C. Altieri
Mol. Cancer Ther. 2006; 5: 478-482. [Abstract] [Full text] [PDF]  

Subject Review
Overcoming Physiologic Barriers to Cancer Treatment by Molecularly Targeting the Tumor Microenvironment

Rob Cairns, Ioanna Papandreou, and Nicholas Denko
Mol. Cancer Res. 2006; 4: 61-70. [Abstract] [Full text] [PDF]  

Review
Sphingolipid targets in cancer therapy

David E. Modrak, David V. Gold, and David M. Goldenberg
Mol. Cancer Ther. 2006; 5: 200-208. [Abstract] [Full text] [PDF]  

Review
Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway

Courtney A. Granville, Regan M. Memmott, Joell J. Gills, and Phillip A. Dennis
Clin. Cancer Res. 2006; 12: 679-689. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17